Short term outcomes of topiramate monotherapy as a first-line treatment in newly diagnosed West syndrome

Korean Journal of Pediatrics

Volumn 54, Issue 9, 2011, Pages 380-384

  Lee, Gyu Min ^a   Lee, Kyung Suk ^a   Lee, Eun Hye ^a   Chung, Sajun ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Monotherapy; Topiramate; West syndrome

Indexed keywords

TOPIRAMATE;

ARTICLE; CHILD; CLINICAL ARTICLE; DROWSINESS; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEEDING; FEMALE; HUMAN; HYPSARRHYTHMIA; INFANT; IRRITABILITY; MALE; MONOTHERAPY; NEUROLOGIC EXAMINATION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME; WEST SYNDROME;

EID: 84863040275     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2011.54.9.380     Document Type: Article

References (39)

1. Juhász C, Chugani HT, Muzik O, Chugani DC. Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome. Brain Dev 2001;23:488-95.
2. Satoh J, Mizutani T, Morimatsu Y. Neuropathology of the brainstem in age-dependent epileptic encephalopathy--especially of cases with infantile spasms. Brain Dev 1986;8:443-9.
3. Baram TZ, Mitchell WG, Hanson RA, Snead OC 3rd, Horton EJ. Cerebrospinal fluid corticotropin and cortisol are reduced in infantile spasms. Pediatr Neurol 1995;13:108-10.
4. Baram TZ, Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 1991;61:97-101.
5. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62:1668-81.
6. Yanagaki S, Oguni H, Hayashi K, Imai K, Funatuka M, Tanaka T, et al. A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev 1999;21:461-7.
7. Baram TZ, Mitchell WG, Tournay A, Snead OC, Hanson RA, Horton EJ. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97:375-9.
8. Bobele GB, Ward KE, Bodensteiner JB. Hypertrophic cardiomyopathy during corticotropin therapy for infantile spasms. A clinical and echocardiographic study. Am J Dis Child 1993;147:223-5.
9. Shamir R, Garty BZ. Pneumocystis carinii pneumonia associated with adrenocorticotropic hormone treatment for infantile spasms. Eur J Pediatr 1992;151:867.
10. Riikonen R, Simell O, Jääskeläinen J, Rapola J, Perheentupa J. Disturbed calcium and phosphate homeostasis during treatment with ACTH of infantile spasms. Arch Dis Child 1986;61:671-6.
11. Appleton RE, Peters AC, Mumford JP, Shaw DE. Randomised, placebocontrolled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 1999;40:1627-33.
12. Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-4.
13. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42:223-86.
14. Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998;39:1324-8.
15. Glauser TA, Miles MV, Tang P, Clark P, McGee K, Doose DR. Topiramate pharmacokinetics in infants. Epilepsia 1999;40:788-91.
16. Mikaeloff Y, de Saint-Martin A, Mancini J, Peudenier S, Pedespan JM, Vallée L, et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res 2003;53:225-32.
17. Zou LP, Ding CH, Fang F, Sin NC, Mix E. Prospective study of firstchoice topiramate therapy in newly diagnosed infantile spasms. Clin Neuropharmacol 2006;29:343-9.
18. Kwon YS, Jun YH, Hong YJ, Son BK. Topiramate monotherapy in infantile spasm. Yonsei Med J 2006;47:498-504.
19. Ben-Menachem E, Sander JW, Stefan H, Schwalen S, Schäuble B. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy. Clin Ther 2008;30:1180-95.
20. Sorel L, Dusaucy-Bauloye A. Findings in 21 cases of Gibbs' hypsarrhythmia; spectacular effectiveness of ACTH. Acta Neurol Psychiatr Belg 1958;58:130-41.
21. Bobele GB, Bodensteiner JB. The treatment of infantile spasms by child neurologists. J Child Neurol 1994;9:432-5.
22. Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, Schmidt D, Reid S, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43.
23. Biton V, Montouris GD, Ritter F, Riviello JJ, Reife R, Lim P, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999;52:1330-7.
24. Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. Neurology 1999;52:1338-44.
25. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. A doubleblind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 1999;52:1882-7.
26. Hsieh MY, Lin KL, Wang HS, Chou ML, Hung PC, Chang MY. Lowdose topiramate is effective in the treatment of infantile spasms. Chang Gung Med J 2006;29:291-6.
27. Korinthenberg R, Schreiner A. Topiramate in children with west syndrome: a retrospective multicenter evaluation of 100 patients. J Child Neurol 2007;22:302-6.
28. Lee IK, Kim SK, Lee R, Kwon YS, Lee JH, Chae JH, et al. Efficacy of topiramate in West syndrome. J Korean Epilepsy Soc 2000;4:27-9.
29. Albsoul-Younes AM, Salem HA, Ajlouni SF, Al-Safi SA. Topiramate slow dose titration: improved efficacy and tolerability. Pediatr Neurol 2004;31:349-52.
30. Peltzer B, Alonso WD, Porter BE. Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms. J Child Neurol 2009;24:400-5.
31. Appleton RE. Vigabatrin in the management of generalized seizures in children. Seizure 1995;4:45-8.
32. Suzuki Y, Nagai T, Ono J, Imai K, Otani K, Tagawa T, et al. Zonisamide monotherapy in newly diagnosed infantile spasms. Epilepsia 1997;38:1035-8.
33. Karvelas G, Lortie A, Scantlebury MH, Duy PT, Cossette P, Carmant L. A retrospective study on aetiology based outcome of infantile spasms. Seizure 2009;18:197-201.
34. Ben-Zeev B, Watemberg N, Augarten A, Brand N, Yahav Y, Efrati O, et al. Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect. J Child Neurol 2003;18:254-7.
35. Kossoff EH, Pyzik PL, Furth SL, Hladky HD, Freeman JM, Vining EP. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002;43:1168-71.
36. Langtry HD, Gillis JC, Davis R. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997;54:752-73.
37. Levisohn PM. Safety and tolerability of topiramate in children. J Child Neurol 2000;15 Suppl 1:S22-6.
38. Sen HA, O'Halloran HS, Lee WB. Case reports and small case series: topiramate-induced acute myopia and retinal striae. Arch Ophthalmol 2001;119:775-7.
39. Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia 1996;37 Suppl 2:S18-22.